mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
-0.086 |
0.6 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.7 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.082 |
0.7 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |